KBC Group NV Has $61,000 Holdings in Ingevity Co. (NYSE:NGVT)

KBC Group NV lifted its position in shares of Ingevity Co. (NYSE:NGVT) by 50.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,574 shares of the company’s stock after acquiring an additional 530 shares during the quarter. KBC Group NV’s holdings in Ingevity were worth $61,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. First Horizon Advisors Inc. grew its holdings in Ingevity by 809.2% during the 2nd quarter. First Horizon Advisors Inc. now owns 591 shares of the company’s stock worth $26,000 after acquiring an additional 526 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Ingevity by 101.8% during the second quarter. Blue Trust Inc. now owns 896 shares of the company’s stock worth $43,000 after purchasing an additional 452 shares during the period. Headlands Technologies LLC bought a new stake in shares of Ingevity in the second quarter worth $46,000. nVerses Capital LLC acquired a new stake in Ingevity in the third quarter valued at $113,000. Finally, Nisa Investment Advisors LLC raised its position in Ingevity by 27.3% during the 3rd quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company’s stock worth $151,000 after purchasing an additional 831 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Ingevity Price Performance

Shares of NGVT opened at $48.56 on Friday. The firm has a market cap of $1.77 billion, a PE ratio of -3.12 and a beta of 1.60. Ingevity Co. has a 52-week low of $30.90 and a 52-week high of $56.29. The business’s 50 day moving average price is $39.55 and its two-hundred day moving average price is $42.09. The company has a debt-to-equity ratio of 6.52, a quick ratio of 1.04 and a current ratio of 1.76.

Ingevity (NYSE:NGVT) last released its earnings results on Tuesday, October 29th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.60 by $0.50. The company had revenue of $376.90 million for the quarter, compared to the consensus estimate of $376.95 million. Ingevity had a negative net margin of 38.11% and a positive return on equity of 24.46%. Ingevity’s quarterly revenue was down 15.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.21 EPS. On average, equities analysts anticipate that Ingevity Co. will post 2.55 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have commented on the company. Wells Fargo & Company cut their target price on Ingevity from $45.00 to $40.00 and set an “equal weight” rating on the stock in a report on Monday, August 5th. CJS Securities upgraded Ingevity from a “market perform” rating to an “outperform” rating and set a $58.00 target price on the stock in a report on Wednesday, August 7th. BMO Capital Markets raised their price target on shares of Ingevity from $40.00 to $47.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Finally, Oppenheimer dropped their price target on shares of Ingevity from $58.00 to $50.00 and set an “outperform” rating on the stock in a research report on Thursday, August 1st. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $52.17.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.